CD40 contributes to lethality in acute sepsis: In vivo role for CD40 in innate immunity

Infection and Immunity

Volumn 71, Issue 6, 2003, Pages 3521-3528

  Gold, Jeffrey A ^a   Parsey, Merdad ^a   Hoshino, Yoshihiko ^a   Hoshino, Satomi ^a   Nolan, Anna ^a   Yee, Herman ^a   Tse, Doris B ^a   Weiden, Michael D ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CECUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNITY; IN VIVO STUDY; INFLAMMATION; LIVER; LUNG; LUNG CAPILLARY; LUNG LAVAGE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL; WILD TYPE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD40; DNA; DNA-BINDING PROTEINS; FEMALE; IMMUNITY, NATURAL; INTERLEUKIN-12; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; SEPSIS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0038781654     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.6.3521-3528.2003     Document Type: Article

References (49)

1. Abraham, E., A. Anzueto, G. Gutierrez, S. Tessler, G. San Pedro, R. Wunderink, A. Dal Nogare, S. Nasraway, S. Berman, R. Cooney, H. Levy, R. Baughman, M. Rumbak, R. B. Light, L. Poole, R. Allred, J. Constant, J. Pennington, and S. Porter. 1998. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351:929-933.
2. Adachi, K., H. Tsutsui, S. Kashiwamura, E. Seki, H. Nakano, O. Takeuchi, K. Takeda, K. Okumura, L. Van Kaer, H. Okamura, S. Akira, and K. Nakanishi. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167:5928-5934.
3. Andrejko, K. M., J. Chen, and C. S. Deutschman. 1998. Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat. Am. J. Physiol. 275:G1423-G1429.
4. Arinobu, Y., R. Sugimoto, M. Akaiwa, K. Arima, T. Otsuka, N. Hamasaki, and K. Izuhara. 2000. Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells. Biochem. Biophys. Res. Commun. 277:317-324.
5. Bernard, G. R., J. L. Vincent, P. F. Laterre, S. P. LaRosa, J. F. Dhainaut, A. Lopez-Rodriguez, J. S. Steingrub, G. E. Garber, J. D. Helterbrand, E. W. Ely, and C. J. Fisher, Jr. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
6. Beutler, B. 2000. Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr. Opin. Microbiol. 3:23-28.
7. Beutler, B., and A. Poltorak. 2001. Sepsis and evolution of the innate immune response. Crit. Care Med. 29:S2-S6. (Discussion, 29:S6-S7.)
8. Bohrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Mannel, B. W. Bottiger, D. M. Stern, R. Waldherr, H. D. Saeger, R. Ziegler, A. Bierhaus, E. Martin, and P. P. Nawroth. 1997. Role of NFkappaB in the mortality of sepsis. J. Clin. Investig. 100:972-985.
9. Calandra, T., B. Echtenacher, D. L. Roy, J. Pugin, C. N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M. P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6:164-170.
10. Chaussabel, D., F. Jacobs, J. de Jonge, M. de Veerman, Y. Carlier, K. Thielemans, M. Goldman, and B. Vray. 1999. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation. Infect. Immun. 67:1929-1934.
11. Clark, E. A., and G. Shu. 1990. Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 145:1400-1406.
12. Echtenacher, B., M. A. Freudenberg, R. S. Jack, and D. N. Mannel. 2001. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect. Immun. 69:7271-7276.
13. Foey, A. D., M. Feldmann, and F. M. Brennan. 2000. Route of monocyte differentiation determines their cytokine production profile: CD40 ligation induces interleukin 10 expression. Cytokine 12:1496-1505.
14. Francis, D. A., J. G. Karras, X. Y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151-161.
15. Gawaz, M., S. Fateh-Moghadam, G. Pilz, H. J. Gurland, and K. Werdan. 1995. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur. J. Clin. Investig. 25:843-851.
16. Green, T. P., D. E. Johnson, R. P. Marchessault, and C. W. Gatto. 1988. Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J. Lab. Clin. Med. 111:173-183.
17. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:635-643.
18. Henn, V., J. R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G. Muller-Berghaus, and R. A. Kroczek. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594.
19. Hoshino, Y., S. Hoshino, K. Nakata, Y. Honda, D. Tse, T. Shioda, W. N. Rom, and M. Weiden. 2002. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J. Exp. Med. 195:495-505.
20. Hwang, Y., M. H. Nahm, D. E. Briles, D. Thomas, and J. M. Purkerson. 2000. Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L. Infect. Immun. 68:511-517.
21. Jyothi, M. D., and A. Khar. 2000. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its tole in the elicitation of an effective antitumor immune response. Cancer Immunol. Immunother. 49:563-572.
22. Kiener, P. A., P. Moran-Davis, B. M. Rankin, A. F. Wahl, A. Aruffo, and D. Hollenbaugh. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:4917-4925.
23. Larsen, C. P., and T. C. Pearson. 1997. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr. Opin. Immunol. 9:641-647.
24. Levy, D. E. 1999. Physiological significance of STAT proteins: investigations through gene disruption in vivo. Cell. Mol. Life Sci. 55:1559-1567.
25. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, R. W. Finberg, R. R. Ingalls, and D. T. Golenbock. 2000. Toll-like receptor 4 imparts ligandspecific recognition of bacterial lipopolysaccharide. J. Clin. Investig. 105:497-504.
26. Matsukawa, A., M. H. Kaplan, C. M. Hogaboam, N. W. Lukacs, and S. L. Kunkel. 2001. Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J. Exp. Med. 193:679-688.
27. McDyer, J. F., T. J. Goletz, E. Thomas, C. H. June, and R. A. Seder. 1998. CD40 ligand/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J. Immunol. 160:1701-1707.
28. Meduri, G. U., S. Headley, G. Kohler, F. Stentz, E. Tolley, R. Umberger, and K. Leeper. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062-1073.
29. Meduri, G. U., G. Kohler, S. Headley, E. Tolley, F. Stentz, and A. Postlethwaite. 1995. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108:1303-1314.
30. Nguyen, V. T., and E. N. Benveniste. 2000. Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J. Biol. Chem. 275:23674-23684.
31. Opal, S. M., C. J. Fisher, Jr., J. F. Dhainaut, J. L. Vincent, R. Brase, S. F. Lowry, J. C. Sadoff, G. J. Slotman, H. Levy, R. A. Balk, M. P. Shelly, J. P. Pribble, J. F. LaBrecque, J. Lookabaugh, H. Donovan, H. Dubin, R. Baughman, J. Norman, E. DeMaria, K. Matzel, E. Abraham, and M. Seneff. 1997. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit. Care Med. 25:1115-1124.
32. Parsey, M. V., R. M. Tuder, and E. Abraham. 1998. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J. Immunol. 160:1007-1013.
33. Piguet, P. F., C. Da Kan, C. Vesin, A. Rochat, Y. Donati, and C. Barazzone. 2001. Role of cd40-cd401 in mouse severe malaria. Am. J. Pathol. 159:733-742.
34. Remick, D., P. Manohar, G. Bolgos, J. Rodriguez, L. Moldawer, and G. Wollenberg. 1995. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89-95.
35. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danforth, R. G. Kunkel, and R. M. Strieter. 1995. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515-1524.
36. Steinhauser, M. L., C. M. Hogaboam, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel. 1999. Multiple roles for IL-12 in a model of acute septic peritonitis. J. Immunol. 162:5437-5443.
37. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49.
38. Tone, M., Y. Tone, J. M. Babik, C. Y. Lin, and H. Waldmann. 2001. The role of Sp1 and NF-κB in regulating CD40 gene expression. J. Biol. Chem. 20:20.
39. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67:2-17.
40. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733-4738.
41. Wang, Y., C. G. Kelly, J. T. Karttunen, T. Whittall, P. J. Lehner, L. Duncan, P. MacAry, J. S. Younson, M. Singh, W. Oehlmann, G. Cheng, L. Bergmeier, and T. Lehner. 2001. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15:971-983.
42. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342:1334-1349.
43. Wheeler, A. P., and G. R. Bernard. 1999. Treating patients with severe sepsis. N. Engl J. Med. 340:207-214.
44. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock - a review of laboratory models and a proposal. J. Surg. Res. 29:189-201.
45. Wiley, J. A., R. Geha, and A. G. Harmsen. 1997. Exogenous CD40 ligand induces a pulmonary inflammation response. J. Immunol. 158:2932-2938.
46. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, and D. A. Ferguson, Jr. 1999. Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality. Ann. Surg. 230:95-104.
47. Yellin, M. J., V. D'Agati, G. Parkinson, A. S. Han, A. Szema, D. Baum, D. Estes, M. Szabolcs, and L. Chess. 1997. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum. 40:124-134.
48. Yoshimoto, T., H. Nagase, T. Ishida, J. Inoue, and H. Nariuchi. 1997. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappaB. Eur. J. Immunol. 27:3461-3470.
49. Zisman, D. A., S. L. Kunkel, R. M. Strieter, J. Gauldie, W. C. Tsai, J. Bramson, J. M. Wilkowski, K. A. Bucknell, and T. J. Standiford. 1997. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349-356.